Virtual Medicinal Product (VMP) - Co-careldopa 625microgram/2.5mg/5ml oral suspension
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Co-careldopa 625microgram/2.5mg/5ml oral suspension | Start Date 01-05-2009 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
- N04BA02
- BNF Codes
-
- BNF code 04090100
| Code | Start Date | End Date |
|---|---|---|
| 15436311000001102 | 01-05-2009 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Carbidopa monohydrate | Based on Base Substance | Carbidopa | 125 microgram | 1 ml |
| Levodopa | Based on Ingredient Substance | 500 microgram | 1 ml |
Name
Levodopa
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
500.0
Strength and UOM (Dmr)
1.0
Name
Carbidopa monohydrate
Basis of strength description
Based on Base Substance
BOSS
Carbidopa
Strength and UOM (Nmr)
125.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMCo-careldopa
-
VMP(Current) Co-careldopa 625microgram/2.5mg/5ml ...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 ml |